Genes, microbes, and T cells--new therapeutic targets in Crohn's disease - PubMed (original) (raw)

Review

Genes, microbes, and T cells--new therapeutic targets in Crohn's disease

Charles O Elson. N Engl J Med. 2002.

No abstract available

PubMed Disclaimer

Similar articles

• Genetic susceptibility and regulation of inflammation in Crohn's disease. Relationship with the innate immune system.
  Peña AS, Peñate M. Peña AS, et al. Rev Esp Enferm Dig. 2002 Jun;94(6):351-60. Rev Esp Enferm Dig. 2002. PMID: 12432592 Review. English, Spanish. No abstract available.
• Crohn's disease is caused by mutations in the bacterial response protein NOD2.
  Press RD. Press RD. Mol Diagn. 2001 Dec;6(4):347-8. Mol Diagn. 2001. PMID: 11837220 No abstract available.
• Towards an understanding of the role of NOD2/CARD15 in the pathogenesis of Crohn's disease.
  Philpott DJ, Viala J. Philpott DJ, et al. Best Pract Res Clin Gastroenterol. 2004 Jun;18(3):555-68. doi: 10.1016/j.bpg.2003.12.004. Best Pract Res Clin Gastroenterol. 2004. PMID: 15157827 Review.
• A frameshift mutation in NOD2 associated with susceptibility to Crohn's disease.
  Ogura Y, Bonen DK, Inohara N, Nicolae DL, Chen FF, Ramos R, Britton H, Moran T, Karaliuskas R, Duerr RH, Achkar JP, Brant SR, Bayless TM, Kirschner BS, Hanauer SB, Nuñez G, Cho JH. Ogura Y, et al. Nature. 2001 May 31;411(6837):603-6. doi: 10.1038/35079114. Nature. 2001. PMID: 11385577
• NOD2 is a negative regulator of Toll-like receptor 2-mediated T helper type 1 responses.
  Watanabe T, Kitani A, Murray PJ, Strober W. Watanabe T, et al. Nat Immunol. 2004 Aug;5(8):800-8. doi: 10.1038/ni1092. Epub 2004 Jun 27. Nat Immunol. 2004. PMID: 15220916

Cited by

• Helicobacter pylori infection and inflammatory bowel disease: is there a link?
  Papamichael K, Konstantopoulos P, Mantzaris GJ. Papamichael K, et al. World J Gastroenterol. 2014 Jun 7;20(21):6374-85. doi: 10.3748/wjg.v20.i21.6374. World J Gastroenterol. 2014. PMID: 24914359 Free PMC article. Review.
• Intestinal microbiota as modulators of the immune system and neuroimmune system: impact on the host health and homeostasis.
  Maranduba CM, De Castro SB, de Souza GT, Rossato C, da Guia FC, Valente MA, Rettore JV, Maranduba CP, de Souza CM, do Carmo AM, Macedo GC, Silva Fde S. Maranduba CM, et al. J Immunol Res. 2015;2015:931574. doi: 10.1155/2015/931574. Epub 2015 Feb 22. J Immunol Res. 2015. PMID: 25759850 Free PMC article. Review.
• Role of the gut microbiota in health and chronic gastrointestinal disease: understanding a hidden metabolic organ.
  Guinane CM, Cotter PD. Guinane CM, et al. Therap Adv Gastroenterol. 2013 Jul;6(4):295-308. doi: 10.1177/1756283X13482996. Therap Adv Gastroenterol. 2013. PMID: 23814609 Free PMC article.
• Oral mixture of autologous colon-extracted proteins for the Crohn's disease: A double-blind trial.
  Israeli E, Zigmond E, Lalazar G, Klein A, Hemed N, Goldin E, Ilan Y. Israeli E, et al. World J Gastroenterol. 2015 May 14;21(18):5685-94. doi: 10.3748/wjg.v21.i18.5685. World J Gastroenterol. 2015. PMID: 25987796 Free PMC article. Clinical Trial.
• Celastrol: A Spectrum of Treatment Opportunities in Chronic Diseases.
  Cascão R, Fonseca JE, Moita LF. Cascão R, et al. Front Med (Lausanne). 2017 Jun 15;4:69. doi: 10.3389/fmed.2017.00069. eCollection 2017. Front Med (Lausanne). 2017. PMID: 28664158 Free PMC article. Review.

Publication types

MeSH terms

Substances

LinkOut - more resources

• Full Text Sources

  • Atypon
  • Ovid Technologies, Inc.

• Other Literature Sources

  • The Lens - Patent Citations Database

• Medical

  • MedlinePlus Health Information